FirstLine Consulting Group provides in-depth analyses of drugs in development to a limited group of buy-side investors.

We produce comprehensive independent research which includes clinical trial analysis, potential for commercial impact, competitive assessment and regulatory information.

Our work is used by clients in the healthcare sector who require greater depth and accuracy in decision making regarding their investments. We provide syndicated reports as well as customized consulting for our clients.

Our Ahead of the Curve™ reports deliver detailed information to investors far ahead of actual data release to maximize investments. Our evidence-based, unbiased research has been considered some of the best on the Street.